Greiling D, Clark R A
Department of Dermatology, School of Medicine, SUNY at Stony Brook, New York 11794-8165, USA.
J Cell Sci. 1997 Apr;110 ( Pt 7):861-70. doi: 10.1242/jcs.110.7.861.
After injury, the wound space is filled with a fibrin/fibronectin clot containing growth factors released by platelets and monocytes. In response to these factors, fibroblasts migrate into the fibrin clot and contribute to the formation of granulation tissue. The functional mechanisms allowing fibroblasts to leave the collagenous matrix of normal connective tissue and invade the provisional matrix of the fibrin clot have not been fully defined. To investigate these mechanisms we established a new in vitro model which simulates specific aspects of early wound healing, that is, the migration of fibroblasts from a three-dimensional collagen matrix into a fibrin clot. This transmigration could be induced by physiological concentrations of platelet releasate or platelet-derived growth factor BB (PDGF-BB) in a concentration-dependent manner. At 24 hours irradiated fibroblasts invaded the fibrin gel almost as well as non-irradiated cells, indicating that transmigration was independent of proliferation. Plasminogen and its activators appear to be necessary for invasion of the fibrin clot since protease inhibitors decreased the amount of migration. These serine proteases, however, were not necessary for exit from the collagen gel as fibroblasts migrated out of the collagen gel onto a surface coated with fibrin fibrils even in the presence of inhibitors. Removal of fibronectin (FN) from either the collagen gel or the fibrin gel markedly decreased the number of migrating cells, suggesting that FN provides a conduit for transmigration. Cell movement in the in vitro model was inhibited by RGD peptide, and by monoclonal antibodies against the subunits of the alpha5 beta1 and alpha v beta3 integrin receptor. Thus, the functional requirements for fibroblast transmigration from collagen-rich to fibrin-rich matrices, such as occurs in early wound healing, have been partially defined using an in vitro paradigm of this important biologic process.
受伤后,伤口部位会充满由血小板和单核细胞释放的生长因子所构成的纤维蛋白/纤连蛋白凝块。成纤维细胞会对这些因子产生反应,迁移至纤维蛋白凝块中,并参与肉芽组织的形成。但成纤维细胞如何离开正常结缔组织的胶原基质并侵入纤维蛋白凝块的临时基质,其功能机制尚未完全明确。为了研究这些机制,我们建立了一种新的体外模型,该模型模拟了早期伤口愈合的特定方面,即成纤维细胞从三维胶原基质迁移至纤维蛋白凝块。这种迁移可由生理浓度的血小板释放物或血小板衍生生长因子BB(PDGF - BB)以浓度依赖的方式诱导。在24小时时,经辐照的成纤维细胞侵入纤维蛋白凝胶的情况与未辐照细胞几乎相同,这表明迁移与增殖无关。纤溶酶原及其激活剂似乎是侵入纤维蛋白凝块所必需的,因为蛋白酶抑制剂会减少迁移量。然而,这些丝氨酸蛋白酶对于从胶原凝胶中移出并非必需,因为即使存在抑制剂,成纤维细胞仍能从胶原凝胶迁移到涂有纤维蛋白原纤维的表面。从胶原凝胶或纤维蛋白凝胶中去除纤连蛋白(FN)会显著减少迁移细胞的数量,这表明FN为迁移提供了通道。体外模型中的细胞运动受到RGD肽以及针对α5β1和αvβ3整合素受体亚基的单克隆抗体的抑制。因此,利用这一重要生物学过程的体外范例,已部分明确了成纤维细胞从富含胶原的基质迁移至富含纤维蛋白的基质(如在早期伤口愈合中发生的情况)的功能需求。